LifeMD, Inc. (LFMD) DCF Valuation

LifEMD, Inc. (LFMD) Évaluation DCF

US | Healthcare | Medical - Pharmaceuticals | NASDAQ
LifeMD, Inc. (LFMD) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

LifeMD, Inc. (LFMD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Découvrez le véritable potentiel de LifEMD, Inc. (LFMD) avec notre calculatrice avancée DCF! Ajustez les hypothèses clés, explorez divers scénarios et évaluez comment les changements affectent la valorisation LifEMD, Inc. (LFMD) - le tout dans un modèle Excel complet.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 12.5 37.3 92.9 119.0 152.5 250.3 410.7 673.9 1,105.7 1,814.2
Revenue Growth, % 0 199.1 149.04 28.16 28.15 64.08 64.08 64.08 64.08 64.08
EBITDA -2.6 -57.5 -53.9 -39.6 -8.2 -108.7 -178.4 -292.8 -480.4 -788.2
EBITDA, % -20.48 -154.14 -58.08 -33.28 -5.38 -43.45 -43.45 -43.45 -43.45 -43.45
Depreciation .3 .4 .9 3.8 6.6 6.1 10.0 16.4 27.0 44.2
Depreciation, % 2.69 1.07 0.9354 3.17 4.33 2.44 2.44 2.44 2.44 2.44
EBIT -2.9 -57.9 -54.8 -43.4 -14.8 -114.3 -187.6 -307.8 -505.0 -828.5
EBIT, % -23.18 -155.2 -59.02 -36.45 -9.71 -45.67 -45.67 -45.67 -45.67 -45.67
Total Cash 1.1 9.2 41.3 4.0 33.1 51.6 84.6 138.9 227.9 373.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 1.0 1.0 2.8 5.3
Account Receivables, % 0.78155 2.68 1.06 2.38 3.46
Inventories 1.0 1.3 1.6 3.7 2.8 8.8 14.5 23.8 39.1 64.1
Inventories, % 7.62 3.39 1.74 3.11 1.81 3.53 3.53 3.53 3.53 3.53
Accounts Payable 3.1 10.4 9.1 10.1 11.1 39.0 64.0 105.0 172.2 282.6
Accounts Payable, % 24.47 27.91 9.75 8.49 7.27 15.58 15.58 15.58 15.58 15.58
Capital Expenditure .0 -.4 -3.4 -12.9 -8.7 -10.7 -17.5 -28.7 -47.1 -77.2
Capital Expenditure, % 0 -1.07 -3.66 -10.83 -5.72 -4.26 -4.26 -4.26 -4.26 -4.26
Tax Rate, % -18.29 -18.29 -18.29 -18.29 -18.29 -18.29 -18.29 -18.29 -18.29 -18.29
EBITAT -2.8 -58.0 -54.8 -43.7 -17.5 -113.5 -186.3 -305.7 -501.6 -823.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -.5 -51.9 -59.0 -55.8 -20.2 -96.2 -177.8 -291.7 -478.6 -785.3
WACC, % 11.3 11.35 11.35 11.35 11.35 11.34 11.34 11.34 11.34 11.34
PV UFCF
SUM PV UFCF -1,211.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -801
Terminal Value -8,578
Present Terminal Value -5,014
Enterprise Value -6,225
Net Debt -14
Equity Value -6,211
Diluted Shares Outstanding, MM 34
Equity Value Per Share -183.19

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: LifeMD, Inc.'s (LFMD) financial data pre-loaded to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive LFMD Data: Pre-filled with LifeMD’s historical performance metrics and future growth estimates.
  • Fully Customizable Parameters: Modify revenue projections, profit margins, discount rates, tax assumptions, and capital investments.
  • Dynamic Valuation Framework: Instantaneous updates to Net Present Value (NPV) and intrinsic value reflecting your adjustments.
  • Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
  • User-Friendly Interface: Intuitive, organized, and crafted for both industry experts and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring LifeMD, Inc. (LFMD) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly observe recalculated results, including LifeMD, Inc.'s (LFMD) intrinsic value.
  • Step 5: Make well-informed investment choices or create reports based on the outputs.

Why Choose LifeMD, Inc. (LFMD) Calculator?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio assessments in a single platform.
  • Flexible Parameters: Modify the highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes LifeMD's intrinsic value and Net Present Value.
  • Ready-to-Use Data: Historical and projected data provide reliable benchmarks for analysis.
  • Expert-Level Tool: Perfect for financial analysts, investors, and business advisors.

Who Should Use This Product?

  • Individual Investors: Gain insights for making informed decisions about buying or selling LifeMD stock (LFMD).
  • Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for LifeMD.
  • Consultants: Provide clients with accurate and timely valuation insights regarding LifeMD's market position.
  • Business Owners: Learn how companies like LifeMD are valued to inform your own business strategies.
  • Finance Students: Explore valuation methodologies using real-life data and examples related to LifeMD.

What the Template Contains

  • Pre-Filled DCF Model: LifeMD, Inc.’s (LFMD) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate LifeMD, Inc.’s (LFMD) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.